Concept of combining potentized drugs evolves from my understanding that potentization involves a process of ‘molecular imprinting’, and individual constituent molecules of drugs are ‘imprinted’ in their individual capacities.
According to this understanding, even a drug we consider ‘single’ is in fact a mixture of different types of ‘molecular imprints’ of diverse constituent drug molecules, and they exist without interacting with each other.
According to this view, even if we mix two or more potentized drugs together, the constituent ‘molecular imprints’ will not interact each other, and will act up on the appropriate molecular targets in their individual capacities.
For the last few years I was experimenting on this issue, and I have found it totally harmless and very effective to combine potentized drugs above 30c, selected on the basis of constitutional as well as particular ‘symptom complexes’.
Hahnemann was talking about SINGLE drug on the basis of scientific knowledge available to him during his period 250 years ago.
He had no idea about the molecular level structure of drug substances, or their molecular level interactions with biological molecules. He had no idea about the molecular level pathology and molecular inhibitions undelying diseases. He considered drugs as ‘single’ substance, and diseases as ‘singular’ entities.
For him, NUX was a ‘single’ substance, whereas we now know NUX tincture is a mixture of hundreds of types of alkaloids, gycosides and other phytochemicals, which act upon our body on the basis of their molecular structure and chemical properties.
All those noises made by CLASSICAL homeopaths over SINGLE DRUG/ MULTIPLE DRUGS issue actually come from their lack scientific understanding of homeopathy.
When a drug substance containing different types of chemical molecules is subjected to potentization, each chemical molecule undergoes molecular imprinting as individual units.
As such, any potentized drug will be a combination of diverse types of molecular imprints representing diverse types of constituent chemical molecules, which can act upon the pathogenic molecules as individual units, in capacity of their individual conformational properties.
When we combine two or more potentized drugs together, all the diverse types of individual molecular imprints contained in those different drugs will exist in that combination as individual units, and act up on pathogenic molecules by their individual conformational properties.
Obviously, a combination of of different potentized drugs will be no way different from a potentized single drug that contains diverse types of chemical molecules.
Molecular imprints act upon pathogenic molecules act as individual units, whether they come from single drug substance or multiple drug substances.
All controversies over single drug/ multiple drugs become totally irrelevant once you realise this scientific truth. But you can understand this truth only if you have a scientific temper, and you are capable of thinking beyond the lessons you learned from organon and your unscientific teachers!
Once homeopathic community could realize and accept the great truth that disease-specific COMBINATIONS of homeopathic drugs in 30c potencies are many many times more effective and safer than so-called SINGLE drugs, homeopathy will be on the top of all medical systems in this world! There will not be any disease that could not be practically cured by using rationally formulated appropriate combinations. All homeopaths should be taught the art and science of preparing and using their own formulations
Whether for prophylactic or curative purpose, you cannot expect a so-called SINGLE homeopathic post-avogadro diluted drug to work as a specific for a DISEASE in a community as a whole.
To be successful, you need to use a well-formulated disease-specific combination of MULTIPLE drugs in post-avogadro dilutions for that purpose.
It is based on this rational idea that we have formulated more than 350 disease-specific post-avogadro MIT FORMULATIONS which are used by homeopaths around the world successfully.
Once you understand MIT explanations of scientific homeopathy, and start perceiving potentized drugs in terms of diverse types of ‘molecular imprints’ as the ‘active principles’ they contain, you will realize that all controversies over ‘single/multiple’ drug issue become totally irrelevant.
According to MIT view, ‘similimum’ essentially means a drug substance that can provide the specific molecular imprints required to remove the particular molecular errors that caused the particular disease condition in the particular patient. Whatever be the ‘method’ by which the drug is selected, similimum is a similimum if it serves the purpose of curing the patient when administered in potentized form.
Since ‘multiple’ molecular errors exist in any patient in a particular point of time, expressed through ‘multiple’ groups of symptoms, he will inevitably need ‘multiple’ molecular imprints to remove them. If potentized form of a ‘single’ medicinal substance can provide all those ‘multiple’ molecular imprints, that ‘single’ drug substance will be enough. If we could not find a ‘single’ drug substance that contain ‘all’ the ‘multiple’ molecular imprints required by the patient as indicated by the ‘symptom groups’, we will have to include ‘multiple’ drug substances in our prescription. It is the constituent molecular imprints contained in our particular prescription that matter.
Important point is, we have to ensure that our prescription supplies all the diverse types of molecular imprints required for deactivating all the diverse types of pathogenic molecules existing in the patient, as indicated by the diverse groups of subjective and objective symptoms expressed by him. If we could find a single drug preparation that could supply all the molecular imprints required by the patient I am dealing with, we can use that single drug preparation only. If we do not find such a single drug, we have to include as many number of drug preparations as required, in order to provide all the molecular imprints needed to remove all the molecular errors in the patient.
‘Single/multiple’ drug controversy never bothers one who understands this scientific approach proposed by MIT, as we start thinking in terms of molecular imprints- not in terms of drug names. Actually, a drug becomes ‘single’, if it contains ‘single’ type of molecular imprints only. IF a drug contains more than one type of molecular imprints, it is a compound drug, even if it is known by a ‘single’ drug name, prepared from a ‘single’ source material, kept in a ‘single’ bottle, consumed as a ‘single’ unit for ‘drug proving’, or considered by ‘masters’ as ‘single’ drug.
When we consume a complex drug substance in crude form, it is absorbed into the blood as various individual chemical molecules contained in it. It is these individual chemical molecules that interact with various biological molecules. Different molecules act up on different biological targets according to the molecular affinities of their functional groups. Biological molecules are inhibited, resulting in errors in the biochemical pathways mediated by those biological molecules. Such molecular level errors in biological processes cascades into a series of molecular errors, which are expressed through various groups of subjective and objective symptoms.
It is obvious that what we consider as the symptoms of that drug substance are actually the sum total of different symptom groups, representing entirely different molecular errors produced in entirely different biological molecules, by the actions of entirely different chemical molecules contained in the crude drug.
We have to remember, there is no such a thing called nux vomica molecule or pulsatilla molecule- only individual chemical molecules contained in nux vomica or pulsatilla tinctures. Each constituent molecule has its own specific chemical structure and properties. They act on different biological targets by their chemical properties.
Each individual chemical molecule contained in a complex crude drug substance acts as an individual drug. That means, nux vomica or pulsatilla are not single drugs as we are taught, but compound drugs. Classical homeopaths may find it difficult to accept this fact, as it contradicts with their beliefs as well as the lessons they are taught. But it is the scientific fact.
From scientific point of view of pharmaceutical chemistry, a drug is a biologically active unit contained in a substance used as therapeutic agent. It is the structure and properties of that chemical molecule that decides its medicinal properties and therapeutic actions. if such as substance contains only one type of biologically active unit, it is a single drug. If it contains different types of biologically active units, it is a compound drug. It is obvious that most of the drugs we use in homeopathy – especially drugs of biological origin and complex minerals- contain diverse types of biologically active units, and hence they cannot be considered single drugs.
Molecular imprinting happens as individual molecules, and as such, potentized drugs prepared from a single drug substance will contain diverse types of molecular imprints representing the diverse types of individual constituent molecules contained in the substance. Those molecular imprints also act as individual units when applied in the organism. Hence, potentized drugs prepared by using a complex, seemingly single drug substance is actually a compound drug, containing diverse types of biologically active units, or ‘molecular imprints’.